Inventor

Fatih M. Uckun

Inventor

White Bear Lake, MN, US

Overview

93→

Patents

1989–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 93 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes33%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%

C07DHeterocyclic compounds15%

C07KPeptides6%

C07HSugars4%

C07CAcyclic or carbocyclic compounds3%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%

C12NMicroorganisms or enzymes1%

A01KAnimal husbandry0%

PatentTitleYear

11,066,421Synthetic cinchona alkaloids against cancer2021 7,186,736'NNI for treatment of multi-drug resistant HIV'2007 7,144,874'Aryl phosphate derivatives of d4T having activity against resistant HIV strains'2006 7,091,351'Vanadium compounds for treating cancer'2006 7,038,049'Haloanilino quinazolines and therapeutic use thereof'2006 7,037,937'Cytotoxic compounds'2006 6,958,359'Vanadium compounds as anti-angiogenic agents'2005 6,953,875'Transgenic zebra fish embryo model for hematopoiesis and lymphoproliferative disorders'2005 6,933,300'JAK-3 inhibitors for treating allergic disorders'2005 6,878,388'Vanadium compounds for treating proliferative cell disorders'2005 6,864,286'Inhibitors of the EGF-receptor tyrosine kinase and methods for their use'2005 6,825,177'Aryl phosphate derivatives of d4T with potent anti-viral activity'2004 6,800,649'Method for inhibiting c-jun expression using JAK-3 inhibitors'2004 6,797,721'Phorboxazole derivatives for treating cancer'2004 6,794,541'Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction'2004 6,774,139'Dual function microbicides'2004 6,753,348'BTK inhibitors and methods for their identification and use'2004 6,743,786'Vanadium compounds for treating cancer'2004 6,734,207'Cytotoxic compounds'2004 6,727,265'Phenoxyethyl-thiourea-pyridine compounds and their use for treatment of HIV-infections'2004 6,689,362'Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP)'2004 6,689,793'Piperidinylethyl-, phenoxyethyl-, and -fluorophenethyl-substituted thiourea compounds with potent anti-HIV activity'2004 6,686,344'Organic-arsonic compounds'2004 6,670,336'Aryl phosphate derivatives of d4T having anti-HIV activity'2003 6,638,939'6,7-dimethoxyquinazolines and therapeutic use thereof'2003 6,627,655'Vanadium (IV) metallocene complexes having spermicidal activity'2003 6,605,589'Cathepsin inhibitors in cancer treatment'2003 6,592,845'Estrogens for treating ALS'2003 6,589,992'Inhibiting collagen-induced platelet aggregation'2003 6,586,450'Phenethyl-thiourea compounds and use'2003 6,552,027'Quinazolines for treating brain tumor'2003 6,545,152'R-isomers of nonnucleoside inhibitors'2003 6,537,975'Aryl phosphate derivatives of d4T having anti-HIV activity'2003 6,537,766'Ikaros isoforms and mutants'2003 6,528,495'Aryl phosphate derivatives of d4T having anti-HIV activity'2003 6,512,003'Synthetic spiroketal pyranes as potent anti-cancer agents and use'2003 6,503,890'Aryl phosphate derivatives of d4T having anti-HIV activity'2003 6,500,860'Vanadium (IV) metallocene complexes having spermicidal activity'2002 6,495,556'Dimethoxy quinazolines for treating diabetes'2002 6,482,828'4-(4-hydroxyphenyl) amino-6,7-dimethoxyquinazoline to prevent development of colorectal cancer'2002 6,482,815'Organic-arsenic compounds'2002 6,482,805'AZT derivatives exhibiting spermicidal and anti-viral activity'2002 6,469,013'Therapeutic compounds'2002 6,469,034'Cyclohexenyl-ethyl-thiourea compounds for inhibiting HIV reverse transcriptase'2002 6,465,450'Vanadium (IV) complexes containing catecholate ligand and having spermicidal activity'2002 6,465,641'One pot synthesis of 5-hydroxy phosphorylated nucleoside derivatives, and compounds formed thereby'2002 6,452,005'JAK-3 inhibitors for treating allergic disorders'2002 6,432,941'Vanadium compounds for treating cancer'2002 6,410,545'Lipid lowering quinazoline dietary supplement composition'2002 6,407,246'Phenethyl-thiourea compounds and use'2002 6,391,921'Treatment of inflammation with 2,4,6-trihydroxy--para-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives'2002 6,376,504'Phenethyl-5-bromopyridlythiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DBABO) derivatives exhibiting spermicidal activity'2002 6,372,217'Methods for the treatment of CD7 viral infection with TXU-7-PAP'2002 6,365,626'BTK inhibitors and methods for their identification and use'2002 6,358,962'6,7-Dimethoxyquinazolines and therapeutic use thereof'2002 6,355,645'Lipid-lowering quinazoline derivative'2002 6,355,678'Inhibitors of the EGF-receptor tyrosine kinase and methods for their use'2002 6,329,420'Tubulin binding compounds (COBRA)'2001 6,326,373'JAK-3 inhibitors for treating allergic disorders'2001 6,319,947'Vanadium (IV) metallocene complexes having spermicidal activity'2001 6,316,454'6,7-Dimethoxy-4-anilinoquinazolines'2001 6,313,129'Therapeutic compounds'2001 6,313,130'JAK-3 inhibitors for treating allergic disorders'2001 6,306,897'Calanolides for inhibiting BTK'2001 6,303,652'BTK inhibitors and methods for their identification and use'2001 6,294,575'BTK inhibitors and methods for their identification and use'2001 6,258,841'Tubulin binding compounds (COBRA)'2001 6,251,882'Alkyl ketones as potent anti-cancer agents'2001 6,248,790'Treatment of inflammation with 2,4,6-trihydroxy-alpha-rho-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives'2001 6,245,808'Oxy-vanadium (IV) complexes having spermicidal activity'2001 6,221,900'BTK inhibitors and methods for their identification and use'2001 6,191,123'Organic-arsenic compounds'2001 6,191,120'Spermicidally active 5-halo-6-alkoxy-5,6-dihydro-2\',3\'-dideoxy-uridines and their pharamaceutical compositions'2001 6,177,433'JAK-3 inhibitors for treating allergic disorders'2001 6,168,932'Recombinant DTctGMCSF fusion toxin in a baculovirus expression vector system'2001 6,160,010'BTK inhibitors and methods for their identification and use'2000 6,150,540'Versatile intermediate for annonaceous acetogenins'2000 6,146,628'Biotherapeutic agents comprising recombinant PAP and PAP mutants'2000 6,136,335'Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity'2000 6,124,324'Thiophene-ethyl thiourea compounds and use'2000 6,080,747'JAK-3 inhibitors for treating allergic disorders'2000 6,080,748'Therapeutic use of JAK-3 inhibitors'2000 6,066,640'Hydroxy-halo-quinazolines for augmentation of mast cell bactericidal activity'2000 6,051,603'Vanadium (IV) metallocene complexes having sperm motility inhibiting activity'2000 6,042,829'Biotherapy of cancer by targeting TP-3/P80'2000 6,034,053'EGF-isoflavone conjugates for the prevention of restenosis'2000 6,030,957'Aryl phosphate derivatives of d4T having anti-HIV activity'2000 5,919,457'TXU-5/B53-PAP antiviral biotherapeutic agent for the treatment of AIDS'1999 5,911,995'EGF-genistein conjugates for the treatment of cancer'1999 5,872,223'Immunoconjugates comprising tyrosine kinase inhibitors'1999 5,690,935'Biotherapy of cancer by targeting TP-3/P80'1997 5,587,459'Immunoconjugates comprising tyrosine kinase inhibitors'1996 4,831,117'Monoclonal antibody specific for human B-cells'1989

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1989Based in Minneapolis, MN, US· patent location history

1996–2004Patents assigned to UNIV MINNESOTA (8)· patent assignee history

1996–2021Based in White Bear Lake, MN, US· patent location history

2000–2007Patents assigned to PARKER HUGHES INST (70)· patent assignee history

2000–2003Patents assigned to HUGHES INST (7)· patent assignee history

2000–2001Patents assigned to WAYNE HUGHES INST (4)· patent assignee history

2021Patents assigned to ARES PHARMACEUTICALS LLC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
PARKER HUGHES INST	70	2000–2007
UNIV MINNESOTA	8	1996–2004
HUGHES INST	7	2000–2003
WAYNE HUGHES INST	4	2000–2001
ARES PHARMACEUTICALS LLC	1	2021

Locations

Location	Patents	Span
White Bear Lake, Minnesota, US	92	1996–2021
Minneapolis, Minnesota, US	1	1989